Jacoby Dana Lynn 4
4 · biote Corp. · Filed May 14, 2025
Insider Transaction Report
Form 4
biote Corp.BTMD
Jacoby Dana Lynn
Director
Transactions
- Award
Deferred Settlement RSU
2025-05-13+21,587→ 21,587 total→ Class A Common Stock (21,587 underlying) - Award
Stock Option (Right to Buy)
2025-05-13+104,547→ 104,547 totalExercise: $3.91Exp: 2035-05-12→ Class A Common Stock (104,547 underlying) - Exercise/Conversion
Class A Common Stock
2025-05-13+12,994→ 63,964 total - Exercise/Conversion
Deferred Settlement RSU
2025-05-13−12,994→ 0 total→ Class A Common Stock (12,994 underlying)
Footnotes (4)
- [F1]Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
- [F2]The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.
- [F3]The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the date of the Reporting Person's separation from service.
- [F4]All shares subject to the option award shall vest on the earlier of May 13, 2026 or the day prior to the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.